Implications of anticoagulant and antiplatelet therapy in patients presenting with hip fractures: a current concepts review

Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy
Vivek GulatiRobert Middleton

Abstract

The increasing use of anticoagulant and antiplatelet therapy for the prevention of thromboembolic disease poses a significant challenge to orthopaedic surgeons treating elderly patients presenting with proximal femoral fractures. Early surgical intervention is known to be beneficial from a clinical perspective and has been encouraged in the UK through the introduction of best practice tariffs providing increased remuneration for prompt treatment. An understanding of the necessary delay to surgery or reversal options for each type of antiplatelet or anticoagulant agent is therefore important. A number of professional bodies have recently produced guidelines that help clinicians manage these patients during the peri-operative period. We review the guidelines relating to antiplatelet and anticoagulant agents during the perioperative period with respect to hip fracture surgery. Antiplatelet agents should not interfere with timing of surgery, but may affect the choice of anaesthetic performed. The action of warfarin should be reversed to expedite surgery. Newer direct oral anticoagulants are more problematic and surgical delay may be necessary, though reversal agents are becoming available.

References

Mar 27, 2004·Clinical Orthopaedics and Related Research·Yoram AneksteinYigal Mirovsky
Jul 7, 2011·The Annals of Pharmacotherapy·Asad E PatanwalaBrian L Erstad
Dec 18, 2013·British Journal of Anaesthesia·A D Oprea, W M Popescu
Apr 30, 2014·The British Journal of Surgery·A LaiJ Thachil
Jan 8, 2015·The New England Journal of Medicine·Anne GodierPascale Gaussem
Jun 23, 2015·The New England Journal of Medicine·Charles V PollackJeffrey I Weitz
Jun 23, 2015·The New England Journal of Medicine·James D DouketisUNKNOWN BRIDGE Investigators
Mar 24, 2016·BMC Musculoskeletal Disorders·Christopher G K M SooMichael A Shatwell
May 6, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Maureen A SmytheJohn Fanikos
Aug 6, 2016·British Journal of Clinical Pharmacology·Luke S FarrowPhyo K Myint
Aug 31, 2016·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN ANNEXA-4 Investigators
Sep 3, 2016·Clinical Orthopaedics and Related Research·John E LawrenceAndrew D Carrothers

❮ Previous
Next ❯

Citations

Dec 7, 2018·Archives of Orthopaedic and Trauma Surgery·Christina RollBernd Kinner
Nov 19, 2020·EFORT Open Reviews·Ioannis V Papachristos, Peter V Giannoudis

❮ Previous
Next ❯

Methods Mentioned

BETA
Flow cytometry

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Nurse Practitioner
Carrie L GriffithsSamantha Hicks
British Journal of Anaesthesia
V Koenig-Oberhuber, M Filipovic
© 2022 Meta ULC. All rights reserved